PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)
304.00
+2.00 (0.66%)
Feb 10, 2026, 11:20 AM WIB
IDX:DGNS Revenue
PT Diagnos Laboratorium Utama Tbk had revenue of 41.39B IDR in the quarter ending September 30, 2025, a decrease of -2.17%. This brings the company's revenue in the last twelve months to 157.99B, down -2.44% year-over-year. In the year 2024, PT Diagnos Laboratorium Utama Tbk had annual revenue of 163.07B with 11.93% growth.
Revenue (ttm)
157.99B
Revenue Growth
-2.44%
P/S Ratio
2.39
Revenue / Employee
1.42B
Employees
111
Market Cap
377.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 163.07B | 17.38B | 11.93% |
| Dec 31, 2023 | 145.70B | -47.19B | -24.47% |
| Dec 31, 2022 | 192.89B | -109.30B | -36.17% |
| Dec 31, 2021 | 302.18B | 119.01B | 64.97% |
| Dec 31, 2020 | 183.17B | 131.83B | 256.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Kalbe Farma Tbk. | 34.38T |
| PT Siloam International Hospitals Tbk | 12.51T |
| PT Soho Global Health Tbk | 10.51T |
| PT Sejahteraraya Anugrahjaya Tbk | 3.30T |
| PT Phapros Tbk | 856.09B |
| PT Ikapharmindo Putramas Tbk | 379.27B |
| PT Royal Prima Tbk | 332.14B |
| PT Indofarma Tbk | 206.24B |